STOCK TITAN

Chemours Names Dawn L. Farrell as Chairperson of its Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
management
Rhea-AI Summary

The Chemours Company (NYSE: CC) has appointed Dawn L. Farrell as Chairperson of the Board of Directors, effective January 1, 2022. Farrell, the current Lead Independent Director, has been with the board since its inception and has extensive experience in the energy sector. Mark Vergnano, the current chairman, will remain a board member. President and CEO Mark Newman expressed confidence in Farrell's leadership and continued collaboration. Chemours is a leader in various chemical markets with around 6,500 employees and operates in about 120 countries.

Positive
  • Dawn L. Farrell's extensive leadership experience may bring fresh perspectives to the board.
  • Continuity in leadership with Mark Vergnano's continued board involvement.
Negative
  • Mark Vergnano's transition away from chairmanship may raise concerns about leadership continuity.

WILMINGTON, Del., Oct. 28, 2021 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions, today announced the appointment of Dawn L. Farrell to Chairperson of the Board of Directors effective January 1, 2022. Mrs. Farrell currently serves as the company's Lead Independent Director and has been a member of the Board of Directors since the company's founding.

"Dawn has been a champion for the best interests of Chemours and all its stakeholders," said Mark Vergnano, chairman of the board of directors at Chemours. "As I reflect on this transition, I'm confident Dawn will continue her relentless dedication as the next Chairperson of the Board."

Mrs. Farrell is a retired energy industry executive and the past President and CEO of TransAlta Corporation. She spent much of her 35-year career in various leadership positions with TransAlta and BC Hydro. She is a member of the board of directors of Canadian Natural Resources Limited, and past member of the board of directors of the Business Council of Canada, Conference Board of Canada and Alberta Business Council.

Mark Vergnano, who assumed chairmanship of the Board of Directors in July to facilitate a smooth leadership transition for the business, will continue to serve as a member of the Board.

"I look forward to continuing the strong working relationship I've had with Dawn and the Board under her leadership as its chairperson in the new year," said Mark Newman, president and chief executive officer of Chemours. "I want to thank Mark for the leadership he has provided since assuming the Board chairmanship and for his continued service to Chemours."

About The Chemours Company
The Chemours Company (Chemours or the Company) (NYSE: CC) is a global leader in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions providing its customers with solutions in a wide range of industries with market-defining products, application expertise and chemistry-based innovations. We deliver customized solutions with a wide range of industrial and specialty chemicals products for markets, including coatings, plastics, refrigeration, and air conditioning, transportation, semiconductor and consumer electronics, general industrial, mining and oil and gas. Our flagship products include prominent brands such as Ti-Pure™, Opteon™, Freon™, Nafion™, Krytox™, Teflon™, and Viton™. In 2019, Chemours was named to Newsweek's list of America's Most Responsible Companies. The company has approximately 6,500 employees and 30 manufacturing sites serving approximately 3,300 customers in approximately 120 countries. Chemours is headquartered in Wilmington, Delaware and is listed on the NYSE under the symbol CC.

For more information, we invite you to visit chemours.com or follow us on Twitter @Chemours or LinkedIn

Forward-Looking Statements 
This press release contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The words "believe," "expect," "will," "anticipate," "plan," "estimate," "target," "project" and similar expressions, among others, generally identify "forward-looking statements," which speak only as of the date such statements were made. These forward-looking statements may address, among other things, the outcome or resolution of any pending or future environmental liabilities, the commencement, outcome or resolution of any regulatory inquiry, investigation or proceeding, the initiation, outcome or settlement of any litigation, changes in environmental regulations in the U.S. or other jurisdictions that affect demand for or adoption of our products, anticipated future operating and financial performance for our segments individually and our company as a whole, business plans, prospects, targets, goals and commitments, capital investments and projects and target capital expenditures, plans for dividends or share repurchases, sufficiency or longevity of intellectual property protection, cost reductions or savings targets, plans to increase profitability and growth, our ability to make acquisitions, integrate acquired businesses or assets into our operations, and achieve anticipated synergies or cost savings, all of which are subject to substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Forward-looking statements are based on certain assumptions and expectations of future events that may not be accurate or realized. These statements are not guarantees of future performance. Forward-looking statements also involve risks and uncertainties that are beyond Chemours' control. In addition, the current COVID-19 pandemic has significantly impacted the national and global economy and commodity and financial markets, which has had and we expect will continue to have a negative impact on our financial results. The full extent and impact of the pandemic is unknown and to date has included extreme volatility in financial and commodity markets, a significant slowdown in economic activity, and increased predictions of a global recession. The public and private sector response has led to significant restrictions on travel, temporary business closures, quarantines, stock market volatility, and a general reduction in consumer and commercial activity globally. Matters outside our control have affected our business and operations and may or may continue to limit travel of employees to our business units domestically and internationally, adversely affect the health and welfare of our personnel, significantly reduce the demand for our products, hinder our ability to provide goods and services to customers, cause disruptions in our supply chains, adversely affect our business partners or cause other unpredictable events. Additionally, there may be other risks and uncertainties that Chemours is unable to identify at this time or that Chemours does not currently expect to have a material impact on its business. Factors that could cause or contribute to these differences include the risks, uncertainties and other factors discussed in our filings with the U.S. Securities and Exchange Commission, including in our Quarterly Report on Form 10-Q for the quarter ended June 30, 2021 and in our Annual Report on Form 10-K for the year ended December 31, 2020. Chemours assumes no obligation to revise or update any forward-looking statement for any reason, except as required by law.

CONTACT:

INVESTORS 
Jonathan Lock 
VP, Corporate Development and Investor Relations
+1.302.773.2263
 
investor@chemours.com 

NEWS MEDIA 
Cassie Olszewski
Media Relations and Financial Communications Manager
+1.302.219.7140
media@chemours.com 

Cision View original content:https://www.prnewswire.com/news-releases/chemours-names-dawn-l-farrell-as-chairperson-of-its-board-of-directors-301411481.html

SOURCE The Chemours Company

FAQ

Who has been appointed as the new chairperson of Chemours?

Dawn L. Farrell has been appointed as the new chairperson of Chemours effective January 1, 2022.

What is Dawn L. Farrell's background?

Dawn L. Farrell is a retired energy industry executive and the former President and CEO of TransAlta Corporation.

What position will Mark Vergnano hold after stepping down as chairperson?

Mark Vergnano will continue to serve as a member of the Board of Directors.

What is Chemours' core business?

Chemours is a global chemistry company specializing in Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions.

How many employees does Chemours have?

Chemours has approximately 6,500 employees worldwide.

The Chemours Company

NYSE:CC

CC Rankings

CC Latest News

CC Stock Data

2.82B
149.41M
0.72%
78.18%
5.35%
Specialty Chemicals
Chemicals & Allied Products
Link
United States of America
WILMINGTON